AVTX: Avalo Therapeutics Inc. Stocks News on November 23, 2024

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

AVTX

GlobeNewswire

11 days ago

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Avalo Therapeutics to Present at Upcoming Investor Conferences

AVTX

GlobeNewswire

12 days ago

Avalo Therapeutics to Present at Upcoming Investor Conferences

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

AVTX

GlobeNewswire

16 days ago

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

AVTX

GlobeNewswire

2 months ago

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Avalo Announces Participation in September Investor Conferences

AVTX

GlobeNewswire

3 months ago

Avalo Announces Participation in September Investor Conferences

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

AVTX

GlobeNewswire

3 months ago

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

AVTX

GlobeNewswire

4 months ago

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

AVTX

GlobeNewswire

4 months ago

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

AVTX

GlobeNewswire

5 months ago

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit

AVTX

GlobeNewswire

5 months ago

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

AVTX

GlobeNewswire

6 months ago

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

AVTX

GlobeNewswire

8 months ago

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Avalo Reports 2023 Financial Results and Provides Business Updates

AVTX

GlobeNewswire

8 months ago

Avalo Reports 2023 Financial Results and Provides Business Updates

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

AVTX

GlobeNewswire

8 months ago

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

AVTX

ACCESSWIRE

10 months ago

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

AVTX

PR Newswire

10 months ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

AVTX

GlobeNewswire

10 months ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

AVTX

GlobeNewswire

a year ago

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

AVTX

GlobeNewswire

a year ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

AVTX

PR Newswire

a year ago

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

AVTX

GlobeNewswire

a year ago

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results

AVTX

GlobeNewswire

a year ago

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List

AVTX

GlobeNewswire

a year ago

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

AVTX

GlobeNewswire

a year ago

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

AVTX

Zacks

a year ago

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

AVTX

Business Wire

a year ago

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

AVTX

PR Newswire

a year ago

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

NanoString Comments on Delaware District Court Verdict

AVTX

Business Wire

a year ago

NanoString Comments on Delaware District Court Verdict

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

AVTX

Simply Wall St.

a year ago

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

AVTX

GlobeNewswire

a year ago

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript

AVTX

Insider Monkey

a year ago

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript

AVTX

Business Wire

a year ago

Mogo Reports Results for Q3 2023

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

AVTX

GlobeNewswire

a year ago

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript

AVTX

Insider Monkey

a year ago

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript

AVTX

Insider Monkey

a year ago

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

AVTX

Insider Monkey

a year ago

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

Kingstone Announces Estimated Third Quarter 2023 Catastrophe

AVTX

ACCESSWIRE

a year ago

Kingstone Announces Estimated Third Quarter 2023 Catastrophe

Seven Hills Realty Trust Announces Third Quarter 2023 Results

AVTX

Business Wire

a year ago

Latest Avalo Therapeutics Inc. (AVTX) News on November 23, 2024

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Avalo Therapeutics to Present at Upcoming Investor Conferences

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Avalo Announces Participation in September Investor Conferences

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Avalo Reports 2023 Financial Results and Provides Business Updates

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

NeuroSense’s (NASDAQ:NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Eco Wave Power Submits an Official Request to the SFSA to Receive an Authorization for the Repurchase of American Depositary Shares Representing Up to 10% of the Company's Shares

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

17 Education & Technology Group Inc. Announces Third Quarter 2023 Unaudited Financial Results

Bitcoin Depot Founder and CEO Brandon Mintz Honored in Forbes 30 Under 30 Finance List

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

NanoString Comments on Delaware District Court Verdict

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

Longeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript

Mogo Reports Results for Q3 2023

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

ShotSpotter, Inc. (NASDAQ:SSTI) Q3 2023 Earnings Call Transcript

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

Kingstone Announces Estimated Third Quarter 2023 Catastrophe

Seven Hills Realty Trust Announces Third Quarter 2023 Results

Share on Social Networks: